Clinical and microbiological aspects of biofilm-associated surgical site infections

Advances in Experimental Medicine and Biology

Volumn 830, Issue , 2015, Pages 47-67

  Edmiston, Charles E ^a   McBain, Andrew J ^b   Roberts, Christopher ^c   Leaper, David ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Clinical Resolutions   (United Kingdom)

^d UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; COLLAGENASE; HYPOCHLORITE; OXYGEN; POVIDONE IODINE; PSEUDOMONIC ACID; STAINLESS STEEL;

ANTIBIOTIC THERAPY; ANTISEPSIS; ARTICLE; BACTERIAL CELL; BACTERIAL SURVIVAL; BIOFILM; BREAST IMPLANT; DEBRIDEMENT; DEVICE REMOVAL; ELECTROSTIMULATION THERAPY; GRAFT INFECTION; HEART SURGERY; HERNIOPLASTY; HUMAN; HYDROCOLLOID; HYDROGEL; HYPERBARIC OXYGEN; INCIDENCE; LOW LEVEL LASER THERAPY; MAGGOT THERAPY; NEUROSURGERY; ORAL SURGERY; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROSTHESIS INFECTION; REOPERATION; SKIN INFECTION; SOFT TISSUE INFECTION; STERNOTOMY; SURGICAL INFECTION; SURGICAL MESH; SURGICAL PATIENT; SURGICAL WIRE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; ULTRASOUND THERAPY; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND CLOSURE; WOUND DEHISCENCE; WOUND DRESSING; WOUND HEALING; WOUND IRRIGATION; BIOLOGICAL MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PROCEDURES; PROSTHESIS-RELATED INFECTIONS; SKIN; SKIN SURGERY; SURGICAL WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; DEBRIDEMENT; DERMATOLOGIC SURGICAL PROCEDURES; HUMANS; MODELS, BIOLOGICAL; PROSTHESIS-RELATED INFECTIONS; SKIN; SURGICAL WOUND INFECTION; WOUND HEALING;

EID: 84926662114     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-11038-7_3     Document Type: Article

References (158)

1. Akers KS, Mende K, Cheatle K, Zera WC, Yu X, Beckius ML, Aggarwal D, Carlos PL, Sanchez CJ, Wenke JC, Weintrob AC, Tribble DR, Murray CK (2014) Biofilms and persistent wound infections in United States military trauma patients a case-control analysis. BMC Infect Dis 14: 190. http://www. biomedcentral. com/1471-2334/14/190.
2. Akiyama H, Ueda M, Kanwaki H, Tada J, Arata J (1997) Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J Dermatol Sci 16: 2-10.
3. Alavi MR, Stojadinovic A, Izadjoo MJ (2012) An overview of biofilm and its detection in clinical samples. J Wound Care 21: 376-383.
4. Allan N, Olson M, Nagel D, Martin R (2010) The impact of hydrosurgical debridement on wounds containing bacterial biofilms. Wound Repair Regen 18: A88.
5. American Society of Plastic Surgeon (2011) Plastic surgery procedural statistics. http://www. plasticsurgery. org. news-and-resources. Accessed 20 Jan 2013.
6. Andriesson AE, Eberlein T (2006) Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds 20: 171-175.
7. Armstrong PA, Bandyk (2006) Management of infected aortic grafts by in-situ grafting. In: Pearce WH, Matsumura JS, Yao JST (eds) Trends in vascular surgery 2005. Greenwood Academic, Evanston, pp 473-48.
8. Attinger C, Wolcott R (2012) Clinically addressing biofilm in chronic wounds. Adv Wound Care 1: 127-132.
9. Back DA, Scheuermann-Poley C, Willy C (2013) Recommendations on negative pressure wound therapy with instillation and antimicrobial solutions-when, where and how to use: what does the evidence show? Int Wound J 10: 32-42.
10. Bandyk DF, Black MR (2005) Infection in prosthetic vascular grafts. In: Rutherford RB, Johnson KW (eds) Vascular surgery, 6th edn. Elsevier Saunders, Philadelphia, pp 875-6894.
11. Barber KE, Werth BJ, McRoberts JP, Rybak MJ (2014) A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 58: 2989-2992.
12. Barnes S, Spencer M, Graham D, Johnson HB (2014) Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control 42: 525-529.
13. Bauer JJ, Harris MT, Kreel I, Gelernt IM (1999) Twelveyear experience with expanded polytetrafluorethylene in the repair of abdominal wall defects. Mt Sinai J Med 66: 20-25.
14. Bellon JM, Garcia-Carranza A, Garcia-Honduvilla N, Carrera-San Martin A, Bujan J (2004) Tissue integration and biomechanical behavior of contaminated experimental polypropylene and expanded polytetrafluoroethylene implants. Br J Surg 91: 489-494.
15. Bigger JW (1944) Treatment of staphylococcal infection with penicillin. Lancet 2: 497-500.
16. Birolini C, de Miranda JS, Utiyama EM, Rasslan S (2014) A retrospective review and observation over a 16-year clinical experience on the surgical treatment of chronic mesh infection. What about replacing a synthetic mesh on the infected surgical field? Hernia Feb 6 [Epub ahead of print].
17. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16: 2-10.
18. Bondurant CP, Jimenez DF (1995) Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23: 254-258.
19. Braxton EE, Ehrlich GD, Hall-Stoodley L, Stoodley P, Veeh R, Fux C, Hu FZ, Quigley M, Post C (2005) Role of biofilms in neurological device-related infections. Neurosurg Rev 28: 249-255.
20. Cameron T (2004) Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg Spine 100: 24-257.
21. Caputo WJ, Beggs DJ, DeFede JL, Simm L, Dharma H (2008) A prospective randomized controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J 5: 288-294.
22. Cardinal M, Eisenbud DE, Armstrong DG, Zelen C, Driver V, Attinger C, Phillips T, Harding K (2009) Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 17: 306-311.
23. Centers for Disease Control and Prevention (2009) Ambulatory surgery in the United States, 2006, National Health Statistics Report, Number 11. http://www. cdc. gov/nchs/data/nhsr/nhsr011. pdf. Revised 4 September 2009.
24. Centers for Disease Control and Prevention (2010) National hospital discharge survey: 2010 table, procedures by selected patient characteristics-number by procedure category and age. http://www. cdc. gov/nchs/fastats/insurg. htm. Accessed 27 Aug 2013.
25. Cho KH, Caparon MG (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 57: 1545-1556.
26. Costerton JW, Stewart PS (2001) Battling biofilms. Sci Am 285: 74-81.
27. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49: 711-745.
28. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persisting infections. Science 284: 1318-1322.
29. Cutting KF, Harding KG (1994) Criteria for identifying wound infection. J Wound Care 3: 198-201.
30. Davidson CA, Lowe CR (2004) Optimization of polymeric surface pre-treatment to prevent bacterial biofilm formation for use in microfluidics. J Mol Recognit 25: 2029-2037.
31. Davis LE, Cook G, Costerton JW (2002) Biofilm on ventriculoperitoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 8: 376-379.
32. Davis SC, Ricotti C, Cazzaniga, Welsh E, Eaglstein WH, Mertz PM (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16: 23-29.
33. De Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37: 387-397.
34. Del Pozo JL, Patel R (2009) Clinical practice. Infection associated with prosthetic joints. N Eng J Med 361: 787-794.
35. Dissemond J, Assadian O, Gerber V, Kingsley A, Kramer A, Leaper DJ, Mosti G, Piatkowski DE, Grzymala A, Riepe G, Risse A, Romanelli M, Strohal R, Traber J, Vasel-Biergans A, Wild T, Eberlein T (2011) Classification of wounds at risk and their antimicrobial treatment with polyhexanide: a practice-oriented expert recommendation. Skin Pharmacol Physiol 24: 245-255.
36. Donlan RM (2001a) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33: 1387-1392.
37. Donlan RM (2001b) Role of biofilms in antimicrobial resistance. ASAIO J 46: 547-552.
38. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D (2008) Polymicrobial nature of chronic diabetic foot ulcer infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3: e3326.
39. Dowsett C (2013) Biofilms: a practice-based approach to identification and treatment. Wounds UK 9: 68-92.
40. Edds EM, Bergamini TM, Brittian KR, Kenneth R (2000) Bacterial components inhibit fibroblast proliferation in vivo. ASAIO J 46: 33-37.
41. Edmiston CE (1993) Prosthetic device infections in surgery. In: Nichols RL, Nyhus LM (eds) Update surgical sepsis. JB Lippincott, Philadelphia, pp 444-468.
42. Edmiston CE, Seabrook GR, Cambria RA, Brown KR, Sommers JR, Krepel CJ, Wilson PJ, Sinski S, Towne JB (2005) Molecular epidemiology of microbial contamination in the operating room environment: is there a risk for infection? Surgery 138: 572-588.
43. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, Brown KR, Towne JB (2006a) Bacterial adherence to surgical sutures: can antimicrobial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203: 481-489.
44. Edmiston CE, Goheen MP, Seabrook GR, Johnson CP, Lewis BD, Brown KR, Towne JB (2006b) Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 192: 344-354.
45. Edmiston CE, Krepel CJ, Marks RM, Rossi PJ, Sanger J, Goldblatt M, Graham MB, Rotherburger S, Collier J, Seabrook GR (2013a) Microbiology of explanted sutures segments from infected and non-infected surgical cases. J Clin Microbiol 51: 417-421.
46. Edmiston CE, Kiernan M, Leaper DJ (2013b) The Ying and Yang of pre-operative screening for methicillin sensitive Staphylococcus aureus (MSSA): would the extra effort and cost of decolonization reduce surgical site infections? Wound Med 1: 7-12.
47. Edmiston CE, Daoud F, Leaper DJ (2013c) Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: a meta-analysis. Surgery 154: 89-100.
48. Edmiston CE, Bruden B, Rucinski M, Henen C, Graham MB, Lewis BL (2013d) Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit? Am J Infect Control 41: S49-S55.
49. Edward R, Harding KG (2004) Bacteria and wound healing. Curr Opin Infect Dis 17: 91-96.
50. Elek SD, Cohen PE (1957) The virulence of S. pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol 38: 573-586.
51. Elgharaby H, Mann E, Awad H, Ganesh K, Ghatak PD, Gordillo G, Sai-Sudhakar CB, Sashwati R, Wozniak DJ (2013) First evidence of sternal wound biofilm following cardiac surgery. PLoS One 8: e70360.
52. Engelsman AF, van der Mei HC, Ploeg RJ, Busscher HJ (2007) The phenomenon of infection with abdominal wall reconstruction. Biomaterials 28: 2314-2327.
53. Engelsman AF, van der Mei HC, Busscher HJ, Ploeg RJ (2008) Morphological aspects of surgical mesh as a risk factor for bacterial colonization. Br J Surg 95: 1051-1059.
54. Evans LV, Lewandowski Z (2000) Structure and function of biofilms. In: Evans LV (ed) Biofilms: recent advances in their study and control. Harwood Academic, Amsterdam, pp 1-17.
55. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA (2008) Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Ostomy Wound Manag S2-S13.
56. Fernandes A, Dias M (2013) The microbiological profile of infected prosthetic implants with an emphasis on which organisms form biofilms. J Clin Diagn Res 7: 219-223.
57. Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE, Bandyk DF (2011) Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovasc Surg 45: 688-696.
58. Gardner SE, Frantz RA, Doebbeling BN (2001) The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 9: 178-186.
59. Gilbert P, McBain AJ (2001) Biofilms: their impact on health and their recalcitrance toward biocides. Am J Infect Control 29: 252-255.
60. Gilbert P, Maira-Litran T, McBain AJ, Rikard AH, Whyte FW (2002) The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 46: 202-256.
61. Griffin JW, Guillot SJ, Redick JA, Browne JA (2012) Removed antibiotic-impregnated cement spacers in two-stage revision joint arthroplasty do not show biofilm formation in vivo. J Arthroplasty 27: 1796-1799.
62. Gunnison JB, Fraher MA, Jawetz E (1964) Persistence of Staphylococcus aureus in penicillin in vitro. J Gen Microbiol 35: 335-349.
63. Hall MR, McGillicuddy E, Kaplan LJ (2014) Biofilm: basic principles, pathophysiology, and implications for clinicians. Surg Infect 15: 1-7.
64. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms from the natural environment to infectious disease. Nat Rev Microbiol 2: 95-108.
65. Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, Costerton JW, Moter A, Bjarnsholt T (2012) Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 65: 127-145.
66. Hamy A, Pessaux P, Mucci-Hennekinne S, Radriamananjo A, Regenet N, Arnaud JP (2003) Surgical treatment of large incisional hernias by intraperitoneal Dacron mesh and an aponeurotic graft. J Am Coll Surg 196: 531-534.
67. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM (2003) A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 29: 631-635.
68. Hart JP, Eginton MT, Brown KR, Seabrook GR, Lewis BD, Edmiston CE, Towne JB, Cambria RA (2005) Operative strategies in aortic graft infections: is complete graft excision always necessary? Ann Vasc Surg 19: 154-160.
69. Hasanadka R, Seabrook GR, Edmiston CE (2007) Vascular graft infections. In: Rello J, Vanes J, Kollef M (eds) Critical care infectious diseases. Kluwer Academic, Boston, pp 555-566.
70. Henry-Stanley MJ, Hess DJ, Barnes AMT, Dunny GM, Wells CL (2010) Bacterial contamination of surgical suture resembles a biofilm. Surg Infect 11: 433-439.
71. Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, Wenzel RP, Pearl TM (2006) A prospective study of outcome, healthcare resource utilization, and cost associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol 27: 1291-1298.
72. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3: 55-65.
73. Holland SP, Pulido JS, Miller D, Ellis B, Alfonso E, Scott M, Costerton JW (1991) Biofilm and scleral buckleassociated infections: a mechanism for persistence. Ophthalmology 98: 933-938.
74. Hoyle B, Corsterton JW (1991) Bacterial resistance to antibiotics: the role of biofilm. Prog Drug Res 37: 91-105.
75. Jacombs A, Tahir S, Hu H, Deva AK, Almatroudi A, Fick WL, Bradshaw DA, Vickery K (2014) In vitro and in vivo investigation of the influence if implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg 133: e471-e2475.
76. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS (2008) Biofilms in chronic wounds. Wound Repair Regen 16: 37-44.
77. Jayaraman R (2008) Bacterial persistence: some new insights into an old phenomenon. J Biosci 33: 795-805.
78. Jenson PO, Givskov M, Bjarnsholt T, Moser C (2011) The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol 59: 292-305.
79. Kaehn K, Eberlein T (2009) In vitro test for comparing the efficacy of wound rinsing solutions. Br J Nurs 18: S4-S10.
80. Kathju S, Nistico L, Hall-Stoodley L, Post JC, Ehrlich GD, Stoodley P (2009) Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surg Infect 10: 457-461.
81. Kathju S, Lask LA, Nistico L, Colella JJ, Stoodley P (2010) Cutaneous fistula from gastric remnant resulting from chronic suture-associated biofilm infection. Obes Surg 20: 251-256.
82. Kessler B, Sendi P, Graber P, Knupp M, Zwicky L, Hintermann B, Zimmerli W (2012) Risk factors for periprosthetic ankle joint infection: a case control study. J Bone Joint Surg Am 94: 1871-1876.
83. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC (2010) Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg 92: 1820-1826.
84. Kingsley A (2001) A pro-active approach to wound infection. Nurs Stand 15: 50-58.
85. Laffer RR, Graber P, Ochsner PE, Zimmerli W (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single center. Clin Microbiol Infect 15: 433-443.
86. Leaper D (2013) Silver dressings: their role in treatment of acute infected wounds. In: Willy C (ed) Antiseptics in surgery-update 2013. Lindqvist Book Publishing, Berlin, pp 151-154.
87. Leaper DJ, Meaume S, Apelqvist J, Teot L, Gottrup F (2011) Debridement methods of non-viable tissue in wounds. In: Farrar D (ed) Advanced wound repair therapies. Woodhead Publishers, Cambridge.
88. Leaper DJ, Ayello EA, Carville K, Fletcher J, Keast D, Lindholm C, Martinez JLL, Mavanini SD, McBain A, Moore Z, Opasanon S, Pina E (2012a) Appropriate use of silver dressings in wounds. International Consensus Document, London.
89. Leaper DJ, Schultz G, Carville K, Fletcher F, Swanson T, Drake R (2012b) Extending the TIME concept: what have we learned in the past 10 years? Int Wound J 9: 1-19.
90. Leber GE, Garb JL, Alexander AI, Reed WP (1998) Longterm complications associated with prosthetic repair of incisional hernias. Arch Surg 133: 378-382.
91. Leid JG, Wilson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK (2005) The exopolysaccharide alginate protects biofilm from IFN-gamma-mediated macrophage killing. J Immunol 175: 7512-7518.
92. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES (2002) Ventriculostomy-related infections; a critical review of the literature. Neurosurgery 51: 170-181.
93. Luijendiik RW, Hop WCJ, van der Tol MP, de Lange DCD, Braaksma MMJ, Ijzermans JNM, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair and mesh repair for incisional hernia. N Engl J Med 343: 392-398.
94. Machairas A, Misiakos EP, Liakakos T, Karatzas G (2004) Incisional hernioplasty with extraperitoneal on-lay polyester mesh. Ann Surg 70: 726-729.
95. Mah TF, O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
96. Massie JB, Heller JG, Abitbol JJ, McPherson D, Garfin SR (1992) Postoperative posterior spinal wound infections. Clin Orthop 284: 99-108.
97. Mauermann WJ, Sampathkumar P, Thompson RL (2008) Sternal wound infections. Best Pract Clin Anesthesiol 22: 423-436.
98. Meier-Davis S (2006) Host response to biofilms, foreign implants and devices. In: Pace JL, Mark E, Rupp Roger GF (eds) Biofilms, infection and antimicrobial therapy. Taylor & Francis Group, Boca Raton, pp 315-317.
99. Ming X, Nichols M, Rothenburger S (2007) In-vivo antibacterial efficacy of Monocryl Plus® antibacterial (poliglecaprone 25 with triclosan) suture. Surg Infect (Larchmt) 8: 1-5.
100. Mosti G, Iabichella ML, Picerni P, Magliaro A, Mattaliano V (2005) The debridement of hard to heal leg ulcers by means of a new device based on Fluid jet technology. Int Wound J 2: 307-314.
101. Nahabedian MY, Tsangaris T, Momen B, Manson PN (2003) Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 112: 467-476.
102. National Institute of Health (2002) Research on microbial biofilms: PA Number: PA-03-047. http://grants. nih. gov/grants/guide/pa-files/PA-03-047. html.
103. National Institute for Health and Clinical Excellence (2013) NICE medical technology scope: Debrisoft for the debridement of acute and chronic wounds. Available at: www. nice. org. uk/nicemedia/live/14185/64407/64407. pdf.
104. Nemoto K, Hirota K, Ono T, Murakami K, Nagao D, Miyake Y (2000) Effect of varidase (streptokinase) on biofilm formed by Staphylococcus aureus. Chemotherapy 46: 111-115.
105. Neto A, Lozano M, Moro MT, Keller J, Carralafuenta C (2002) Determinants of wound infection after surgery for breast cancer. Zentralbl Gynakol 124: 429-433.
106. Netscher DT (2004) Subclinical infection as a possible cause of significant breast capsules. Plast Reconstr Surg 113: 2229-2230.
107. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ (2008) Hospital-associated cost due to surgical site infection after breast surgery. Arch Surg 143: 53-56.
108. Otto M (2008) Staphylococcal biofilm. Curr Top Microbiol Immunol 322: 207-228.
109. Owen S, Ramraj V, Wallop J (2010) The cardiac surgery advance practice group: a case study of APN and PA collaborative practice. J Nurs Pract 6: 371-374.
110. Pandey R, Berendt AR, Athanasou NA (2000) Histological and microbiological findings in non-infected and infected revision arthroplasty tissue. The OSIRIS Collaborative Study Group, Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg 120: 570-574.
111. Parsa K, Schaudinn C, Gorur A, Sedghizadeh PP, Johnson T, Tse DT, Costerton JW (2010) Demonstration of bacterial biofilms in culture-negative silicone stent and jones tubes. Ophthal Plast Reconstr Surg 26: 426-430.
112. Parsek MR, Greenberg EP (2005) Sociomicrobiology-the connection between quorum sensing and biofilms. Trends Microbiol 13: 27-33.
113. Percival SL (2004) Biofilms and their potential role in wound healing. Wound 16: 234-240.
114. Percival SL (2011) Biofilms and their management: form concept to clinical reality. J Wound Care 20: 220-226.
115. Percival SL, Thomas JG, Williams DW (2010) Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J 7: 169-175.
116. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW (2012) A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 20: 647-657.
117. Phillips PL, Wolcott RD, Fletcher J, Schultz GS (2010a) Biofilms made easy. Wounds Int 1: 1-6.
118. Phillips PL, Yang Q, Sampson E, Schultz G (2010b) Effects of antimicrobial agents on an in vitro biofilm model of skin wounds. Adv Wound Care 1: 299-304.
119. Raju DR, Jindrak K, Weiner M, Enquist IF (1977) A study of the critical bacterial inoculums to cause a stimulus to wound healing. Surg Gynecol Obstet 144: 347-350.
120. Ray JM, Triplett G (2011) What is the role of biofilms in severe head and neck infections? Oral Maxillofac Surg Clin North Am 23: 497-505.
121. Reed D, Kemmerly SA (2009) Infection control and prevention: a review of hospital-acquired infections and the economic implications. Ochsner J 9: 27-31.
122. Rhoads DD, Wolcott RD, Percival SL (2008) Biofilms in wounds management strategies. J Wound Care 17: 502-508.
123. Rieger UM, Kalbermatten DF, Haug M, Frey HP, Pico R, Frei R, Pierer G, Luscher NJ, Trampuz A (2013) Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg 100: 768-774.
124. Romling U, Balsalobre C (2012) Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 272: 541-561.
125. Rothenburger S, Spangler D, Bhende S, Burkley D (2002) In-vitro antimicrobial evaluation of coated Vicryl Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assay. Surg Infect 3: S79-S87.
126. Samini DB, Bielory BP, Miller D, Johnson TE (2013) Microbiologic trends and biofilm growth on explanted periorbital biomaterials: a 30-year review. Opthal Plast Reconstr Surg 29: 376-381.
127. Sanchez CJ, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK (2013) Biofilm formation by clinical isolates and the implication in chronic infections. BMC Infect Dis 13: 47. http://www. biomedcentral. com/1571-2334/13/47.
128. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184: 1140-1154.
129. Scott NW, McCormack K, Graham P, Go PM, Ross SJ, Grant AM (2002) Open mesh versus non-mesh repair for femoral and inguinal hernia. Cochrane Database Syst Rev CD002197.
130. Seaton RA, Malizos KN, Viale P, Gargalianos-Kakolyris P, Santantonio T, Petrelli E, Pathan R, Heep M, Chaves R (2013) Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-COREsm database. J Antimicrob Chemother 68: 1642-1649.
131. Shepard J, Ward W, Milstone A, Carlson T, Frederick J, Hadhazy E, Perl T (2013) Financial impact of surgical site infections on hospital: the hospital management perspective. JAMA Surg. doi: 10. 1001/jamasurg. 2013. 2246.
132. Sibbald RG, Leaper DJ, Queen D (2011) Iodine made easy. Wounds Int 2: s1-s6.
133. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555.
134. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa has similar resistance to killing by antimicrobial. J Bacteriol 183: 6746-6751.
135. Steckelberg JM, Osmom DR (2000) In: Waldvogel FA (ed) Prosthetic joint infection: infections associated with indwelling medical devices, 3rd edn. ASM Press, Washington, DC, pp 173-205.
136. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138.
137. Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Review. Biofilms as complex differentiated communities. Annu Rev Microbiol 56: 187-209.
138. Subramani K, Jung RE, Molenberg A, Hammerle CH (2009) Biofilm on dental implants: a review of the literature. Int J Oral Maxillofac Implants 24: 616-626.
139. Sugita J, Yokoi N, Fullwood NJ, Quantock AJ, Takada Y, Nakamura Y, Kinoshita S (2001) The detection of bacterial biofilms in punctual plug holes. Cornea 20: 362-365.
140. Sun Y, Dowd SE, Smith E, Rhoads DD, Walcott RD (2008) In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen 16: 805-813.
141. Tran CL, Langer S, Broderick-Villa G, DiFronzo LA (2002) Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer? Am Surg 69: 852-856.
142. Tsoi B, Ziolkowoski NI, Thoma A, Campbell K, O'Reilly D, Goeree R (2014) Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg 133: 234-249.
143. Umemura A, Jaggi JL, Hurthi HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH (2003) Deep brain stimulation for movement disorder: morbidity and mortality in 109 patients. J Neurosurg 98: 779-784.
144. Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D (2003) Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg 103: 98-101.
145. Vanwijck R, Kaba L, Boland S, Gonzales y Azero M, Delange A, Tourbach S (2010) Immediate skin grafting of sub-acute and chronic wounds debrided by hydrosurgery. J Plast Reconstr Aesthet Surg 63: 544-549.
146. Varma S, Ferguson HC, Breen DV, Lumb WV (1974) Comparison of seven suture materials in infected wounds: an experimental study. J Surg Res 17: 165-170.
147. Walker TS, Tomlin KL, Woethern GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA (2005) Enhanced Pseudomonas biofilm development mediated by human neutrophils. Infect Immun 73: 3693-3701.
148. White W (2011) Sharp wound debridement in the management of recalcitrant, locally infected chronic venous leg ulcers: a narrative review. Wound Pract Res 19: 222-228.
149. Williams DL, Costerton JW (2012) Using biofilms as initial inocula in animal models of biofilm-related infections. J Biomed Mater Res B Appl Biomater 100: 1163-1169.
150. Wolcott RD, Cox S (2013) More effective cell-based therapy through biofilm suppression. J Wound Care 22: 26-31.
151. Wolcott RD, Rhoads DD (2008) A study of biofilm-based wound management in subjects with critical limb ischemia. J Wound Care 17: 145-155.
152. Wolcott RD, Rhoads D, Dowd SE (2008) Biofilms and chronic wound inflammation. J Wound Care 17: 333-341.
153. Wolcott RD, Kennedy JP, Dowd SE (2009) Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 18: 54-56.
154. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE (2010a) Chronic wounds and the medical biofilm paradigm. J Wound Care 19: 45-53.
155. Wolcott RD, Rumbaugh KP, Stewart PS, Dowd SE (2010b) Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 19: 320-328.
156. Wood HL, Holden SR, Bayston R (2001) Susceptibility of Staphylococcus epidermidis biofilm in CSF shunts to bacteriophage attack. Eur J Pediatr Surg 11: S56-S57.
157. Zhao G, Usui ML, Lippmann SI, James GA, Stewart PS, Fleckman P, Olerud JE (2013) Biofilms and inflammation in chronic wounds. Adv Wound Care 2: 389-399.
158. Zimmerli W, Moser C (2012) Pathogenesis and treatment concepts of orthopedic biofilm infections. FEMS Immunol Med Microbiol 65: 158-168.